Osimertinib for patients with poor performance status and EGFR T790M mutation-positive advanced non-small cell lung cancer: a phase II clinical trial
Nakashima, Kazuhisa, Ozawa, Yuichi, Daga, Haruko, Imai, Hisao, Tamiya, Motohiro, Tokito, Takaaki, Kawamura, Takahisa, Akamatsu, Hiroaki, Tsuboguchi, Yuko, Takahashi, Toshiaki, Yamamoto, Nobuyuki, MoriJournal:
Investigational New Drugs
DOI:
10.1007/s10637-020-00943-0
Date:
May, 2020
File:
PDF, 318 KB
2020
File converter
More search results
More benefits 
